The *Burkholderia cepacia* complex (Bcc) is a group of closely related gram-negative bacteria comprising at least 9 species ([@R1]). They are routinely isolated from the natural environment, where they can have a range of beneficial properties ([@R2]). However, these bacteria can also frequently cause fatal infections in vulnerable humans, such as those who have cystic fibrosis (CF). Because Bcc bacteria are not normally carried as commensal organisms, the main sources of infection are considered to be patient-to-patient spread ([@R3],[@R4]); hospital settings, including medical devices and contaminated disinfectants; and the environment ([@R5],[@R6]). Therefore, although Bcc species may have an important environmental role in agriculture and biotechnology industries, their use also represents a potential clinical risk to susceptible members of the community ([@R7]*,*[@R8]). All species of Bcc can be isolated from the environment in differing degrees ([@R2]). Similarly, all current Bcc species have been cultured from CF patient sputum ([@R2]). Infection control measures have been implemented to reduce patient-to-patient transmission; although effective, these measures have not prevented the emergence of new infection. Thus, the environment could be acting as a constant nonpatient reservoir for infectious Bcc pathogens.

Previous studies have reported the possibility of humans acquiring Bcc directly from natural environments (*9*,[@R10]). The most recent of these studies reported evidence that a *B. cenocepacia* strain, isolated from soil, was indistinguishable by several typing methods (pulsed-field gel electrophoresis \[PFGE\] genomic fingerprinting and repetitive extragenic palindromic \[rep\]--PCR) from isolates of the problematic CF lineage PHDC ([@R10]).

The Study
=========

To evaluate how widespread the emergence of environmental isolates as causes of clinical infections may be, we used a highly discriminatory and transportable typing method to study isolates from several large bacterial culture collections. Multilocus sequence typing (MLST) is a relatively new technique based upon unambiguous sequence analysis of several housekeeping genes. Unlike previous methods for Bcc strain typing ([@R10]), MLST is not based on banding patterns but instead relies on the robust comparison of DNA sequence information. This process facilitates both the identification and matching of identical clones as well as their evolutionary comparison to closely related strains.

Using a recently validated MLST scheme ([@R11]), we analyzed a collection of 381 clinical isolates of all 9 currently reported Bcc species, from 28 countries. A total of 187 distinct sequence types (STs) were identified from clinical isolates within this collection and compared with 233 environmental Bcc isolates (113 STs). We found that 81 clinical isolates (encompassing15 STs) were identical by MLST to a wide range of environmental isolates. This figure represents 21.5% of the clinical isolates examined (for clarity, a subset are shown in the [Table](#T1){ref-type="table"}; \[[@R12]\]).

###### MLST analysis of the *Burkholderia cepacia* strains showing their species, source, and geographic location\*

  Bcc species             ST    Isolate name    Source   Country          Source of isolate:   Year of isolation
  ----------------------- ----- --------------- -------- ---------------- -------------------- -------------------
                          1     ATCC 17759†     ENV      Trinidad         Soil                 1958
                          1     LMG 14087       NON      UK               Wound                1988
                          10    ATCC 25416^T^   ENV      USA              Onion                1948
                          10    J1050           NON      USA              Human                Before 1983
                          266   BC20            ENV      USA              Water                --
                          266   AU6671          NON      U.S.             Wound                --
                          365   HI-3602         ENV      USA              Soil                 --
                          365   C8509           CF       Canada           Sputum               1999
                          365   AU3206          CF       USA              Sputum               --
  *B.* multivorans                                                                             
                          21    ATCC 17616†     ENV      USA              Soil                 Before 1966
                          21    AU0453          CF       USA              Sputum               --
                          21    C9140           CF       Canada           Sputum               2000
                          375   R-20526         ENV      Belgium          River water          2002
                          375   IST455          CF       Portugal         Sputum               2000
  *B.* cenocepacia IIIA                                                                        
                          32    POPR8           ENV      Mexico           Radish               --
                          32    5--457          CF       Czech Republic   Sputum               2002
                          32    R-16597         CF       Belgium          Sputum               2001
                          32    BCC1118         NON      UK               Wound                Before 1994
  *B.* cenocepacia IIIB                                                                        
                          37    BC-1            ENV      USA              Maize rhizosphere    --
                          37    AU2362          CF       USA              Sputum               2000
                          122   HI-2424         ENV      USA              Soil                 --
                          122   AU1054          CF       USA              CF                   --
                          122   CEP0497         NON      Canada           Leg ulcer            1995
  *B.* stabilis                                                                                
                          50    LMG 14294†      CF       Belgium          Sputum               1993
                          50    R-16919         ENV      Belgium          Industrial           --
                          50    LMG 14086†      ENVH     UK               Respirator           1970
                          51    HI-2482         ENV      USA              Shampoo              --
                          51    ATCC 35254      ENVH     USA              Medical solution     1980
                          51    CEP0928         ENVH     USA              Albuterol solution   --
                          51    LMG 14291       CF       Belgium          Sputum               1993
                          51    LMG 7000        NON      Sweden           Blood                1983
  *B.* vietnamiensis                                                                           
                          61    J1702           ENVH     USA              Hospital equipment   --
                          61    BCC0190         CF       USA              Sputum               --
                          61    J1712           NON      USA              Wound                --
                          61    J1738           NON      USA              Wound                --
                          61    J1742           NON      USA              Wound                --
                          67    R-20590         ENV      Belgium          River water          2002
                          67    D0774           CF       Canada           Sputum               2003
  B. ambifaria                                                                                 
                          81    MVP-C2-4        ENV      Italy            Maize rhizosphere    1996
                          81    BCC0250†        CF       Australia        Sputum               1994
                          77    AMMD^T^         ENV      USA              Soil                 1985
                          77    AU0212          CF       USA              Sputum               --

\*MLST, multilocus sequence typing; Bcc, *B. cepacia* complex; ST, sequence type; ENV, isolated from the environment; NON, isolated from a non-cystic fibrosis (CF) patient; CF, isolated from a CF patient; IIIA or IIIB, isolates belonging to *B. cenocepacia recA* subgroup A or B, respectively; ENVH, isolated from a hospital environment. †, panel strain ([@R12]); suprascript T, type strain for species.

The resolution of strain identification offered by MLST is such that different isolates sharing the same ST (genotypically indistinguishable at all 7 loci) are defined as clones of the same strain (e.g., for a group of isolates within this collection, we have further validated this identity by cloning and sequencing up to 10 random fragments of DNA). The 15 STs identified from environmental and clinical sources belonged to 6 different Bcc species ([Table](#T1){ref-type="table"}): *B. cepacia* (4 STs), *B. multivorans* (2 STs), *B. cenocepacia* (3 STs), *B. stabilis* (2 STs), *B. vietnamiensis* (2 STs), and *B. ambifaria* (2 STs). Three *B. cenocepacia* STs also belonged to 2 different *recA* lineages defined within this species: IIIA (1 ST) and IIIB (2 STs).

Conclusions
===========

STs occurring in both clinical and environmental niches were found in 6 of the 9 formally described Bcc; the greatest degree of overlap occurred in *B. cepacia* and *B. stabilis* ([Figure](#F1){ref-type="fig"}). The proportion of STs not shared between clinical and environmental isolates varied for each Bcc species we examined. This finding may reflect the few clinical or environmental isolates for that species or high genetic diversity; a larger sample size is needed to find identical matches. Species dominated by clinical STs (\>83% of STs) were *B. multivorans, B. cenocepacia recA* lineage IIIA, and *B. dolosa.* Those species containing mainly environmental STs (\>80%) were *B. ambifaria, B. anthina,* and *B. pyrrocinia* ([Figure](#F1){ref-type="fig"}). Although this distribution agrees with findings of previous studies ([@R2]), it also reflects the distribution of isolates within the collections from which isolates were obtained.
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Several ST matches between clinical and environmental isolates were of particular interest. MLST ST-10 was shared by *B. cepacia* J1050, a human isolate cultured in the United States (Cleveland, Ohio) and the type strain for *B. cepacia* ATCC 25416, isolated from an onion. This evidence of clonality augments the clonal relationship reported earlier ([@R9]) between ATCC 25416 and a UK isolate from a CF patient. The *B. multivorans* IST455 isolated from a CF patient's sputum in Portugal, as reported in a previous study ([@R13]) had the same sequence type (ST-375) as R-20526, which was isolated from the River Schelde in Belgium.

*B. cenocepacia recA* lineage IIIA isolates with ST-32 ([Table](#T1){ref-type="table"}) were from 4 independent sources: POPR8 (isolated from a radish in Mexico), BCC1118 (isolated from a UK non-CF patient infection), R-16597 (isolated from a CF patient in Belgium), and 5--457 (isolated from a CF patient in the Czech Republic). ST-32 appears to be a globally distributed, predominantly clinical strain (A. Baldwin, unpub. data). The *B. cenocepacia recA* lineage IIIB isolates identified as ST-122 ([Table](#T1){ref-type="table"}) include the PHDC strains, predominant in US CF patients (AU1054) and previously found in US soil (HI-2424) ([@R10]), and CEP0497, which was obtained from a leg wound in a non-CF patient in Canada. Together with a recent report of PHDC strains identified in Europe ([@R14]), the Canadian isolate in our study adds further weight to the identification of this ST as a globally distributed strain.

MLST analysis of *B. stabilis* corroborated the high degree of clonality observed by PFGE fingerprint analysis in the original description of this species ([@R15]). However, MLST was further able to distinguish 8 STs among the 26 isolates examined, which indicates that MLST may be a more effective method than PFGE for epidemiologic analysis of *B. stabilis*. This increased resolution adds to the observation that 2 *B. stabilis* STs are globally distributed and isolated from clinical samples and an array of different niches, including domestic products, medical solutions, industrial process contaminants, and hospital devices.

In summary, \>20% of the clinical isolates we examined were indistinguishable by MLST from isolates from environmental sources. This finding suggests that conservation of intrinsic determinants necessary to thrive in environmental niches may confer an ability to colonize susceptible humans. Further work is urgently required to more extensively investigate the emergence of pathogenic members of the Bcc in the natural environment and the risk for infection this may represent.
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